Condition: Artery Disease · Sponsor: iVascular S.L.U.
The rationale of this study is to confirm and support the clinical safety and performance of any of these products in a real-world population of 209 patients who underwent an endovascular intervention within standard-of-care of the iliacofemoral artery and renal artery, using at least one of the investigational products from iVascular.
This description comes directly from the study's public registry record.
Mieke Ramsdonck · +32 479 64 37 60 · mieke.ramsdonck@fcre.eu
Always discuss trial participation with your own doctor first.
| CH Henri Duffaut | Avignon, France | Active Not Recruiting |
| Clinique Synergia Ventoux | Carpentras, France | Recruiting |
| Polyclinique Inkermann | Niort, France | Recruiting |
| L'Hôpital Privé Des Côtes D'Armor | Plérin, France | Recruiting |
| Hôpital d'instruction des Armées Sainte Anne | Toulon, France | Recruiting |
| Hôpital Privé Toulon Hyeres St. Jean | Toulon, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05902923